Lost in translation? Learning from the opioid epidemic in the USA

Anaesthesia

Volumn 68, Issue 12, 2013, Pages 1215-1219

  Weisberg, D ^a   Stannard, C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; METHADONE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CANCER PAIN; CHRONIC PAIN; DRUG ANTAGONISM; DRUG COST; DRUG DEPENDENCE; DRUG INDUSTRY; DRUG INTOXICATION; DRUG MISUSE; DRUG SAFETY; DRUG TRAFFIC; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; OPIATE ADDICTION; PAIN; PRESCRIPTION; QUALITY OF LIFE; RESPIRATION DEPRESSION; UNITED KINGDOM; UNITED STATES;

ANALGESICS, OPIOID; GREAT BRITAIN; HUMANS; OPIOID-RELATED DISORDERS; PAIN; PAIN MANAGEMENT; PRESCRIPTION DRUG MISUSE; UNITED STATES;

EID: 84887694751     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12503     Document Type: Editorial

References (42)

1. Kotecha MK, Sites BD,. Pain policy and abuse of prescription opioids in the USA: a cautionary tale for Europe. Anaesthesia 2013; 68: 1210-15.
2. Zin CS, Chen LC, Knaggs RD,. Total number of prescriptions and number of patients stratified by non-cancer and cancer pain CPRD 2000-2010. Pharmacoepidemiology and Drug Safety 2012; 3: 403.
3. World Health Organization. Cancer Pain Relief. Geneva: World Health Organization, 1996: 74.
4. Moore RA, Derry S, McQuay HJ, Wiffen PJ,. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2011; 9: CD008659.
5. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK,. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006; 125: 172-9.
6. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010; 1: CD006605.
7. Gureje O, Von Korff M, Simon GE, Gater R,. Persistent pain and well-being: a World Health Organization Study in Primary Care. Journal of the American Medical Association 1998; 280: 147-51.
8. Institute of Medicine. Relieving Pain in America: a Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: The National Academies Press, 2011.
9. Demyttenaere K, Bruffaerts R, Lee S, et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain 2007; 129: 332-42.
10. Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK,. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain 2011; 152: 488-97.
11. Sullivan MD, Howe CQ,. Opioid therapy for chronic pain in the US: promises and perils. Pain 2013 Sept 13; doi 10.1016/j.pain.2013.09.009.
12. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Annals of Internal Medicine; 152: 85-92.
13. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. Journal of the American Medical Association 2011; 305: 1315-21.
14. Duthey B, Scholten W,. Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. Journal of Pain and Symptom Management 2013 July 18; doi 10.1016/j.jpainsymman.2013.03.015.
15. Lohman D, Schleifer R, Amon JJ,. Access to pain treatment as a human right. BMC Medicine 2010; 8: 8.
16. Drug Control and Access to Medicines Consortium. Opioid Consumption Motion Chart. http://ppsg-production.heroku.com/chart (accessed 30/09/2013).
17. Health and Social Care Information Centre. Prescriptions Dispensed in the Community: Statistics for England 2002-2012 http://www.hscic.gov.uk/ searchcatalogue?productid=12055&returnid=1683 (accessed 01/08/2013).
18. Office for National Statistics. Deaths related to drug poisoning in England and Wales, 2012. http://www.ons.gov.uk/ons/dcp171778-320841.pdf (accessed 01/09/2013).
19. Vital signs: risk for overdose from methadone used for pain relief-United States, 1999-2010. MMWR Morbity and Mortality Weekly Report 2012; 61: 493-7.
20. Health and Social Care Information Centre. Prescribing and Primary Care: Prescription Cost Analysis-England, 2011. http://www.ic.nhs.uk (accessed 01/09/2013).
21. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. Journal of the American Medical Association 2008; 300: 2613-20.
22. Jones JD, Mogali S, Comer SD,. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence 2012; 125: 8-18.
23. International Narcotics Control Board. Psychotropic Substances: Statistics for 2011, Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971. New York: United Nations Publications, 2012.
24. The National Treatment Agency for Substance Misuse. Addiction to Medicine. http://www.nta.nhs.uk 2011 (accessed 01/09/2013).
25. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. Rockville, MD: Health and Human Services Publication, 2009.
26. Inciardi JA, Surratt HL, Cicero TJ, Beard RA,. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Medicine 2009; 10: 537-48.
27. United Nations Office on Drugs and Crime. World Drug Report 2012. New York: United Nations Publications, 2013.
28. Strang J, Hall W, Hickman M, Bird SM,. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland. British Medical Journal 2010; 341: c4851.
29. Paulozzi LJ, Kilbourne EM, Desai HA,. Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine 2011; 12: 747-54.
30. Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR,. Prescription opioid usage and abuse relationships: an evaluation of State prescription drug monitoring program efficacy. Substance Abuse: Research and Treatment 2009; 3: 41.
31. Reifler LM, Droz D, Bailey JE, et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine 2012; 13: 434-42.
32. Dormuth CR, Miller TA, Huang A, Mamdani MM, Juurlink DN,. Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. Canadian Medical Association Journal 2012; 184: E852-6.
33. Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P,. A statewide prescription monitoring program affects emergency department prescribing behaviors. Annals of Emergency Medicine 2010; 56: 19-23.
34. Green TC, Mann MR, Bowman SE, et al. How does use of a prescription monitoring program change medical practice? Pain Medicine 2012; 13: 1314-23.
35. Becker WC, Fiellin DA,. Federal plan for prescriber education on opioids misses opportunities. Annals of Internal Medicine 2012; 157: 205-6.
36. Fischer B, Keates A, Buhringer G, Reimer J, Rehm J,. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction 2013 May 20; doi 10.1111/add.12224.
37. Care Quality Commission. Annual Report and Accounts 2010 /2011. http://www.cqc.org.uk 2011 (accessed 01/09/2013).
38. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN,. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Canadian Medical Association Journal 2009; 181: 891-6.
39. Care Quality Commission. The safer management of controlled drugs, 2012. http://www.cqc.org.uk/sites/default/files/media/documents/cdar-2012.pdf (accessed 01/09/2013).
40. Rose N,. Neurochemical selves. Society 2003; 41: 46-59.
41. Wallace AS, Freburger JK, Darter JD, Jackman AM, Carey TS,. Comfortably numb? Exploring satisfaction with chronic back pain visits. Spine Journal 2009; 9: 721-8.
42. Centers for Disease Control and Prevention. Unintentional drug poisoning in the United States. http://www.cdc.gov/HomeandRecreationalSafety/pdf/poison- issue-brief.pdf (accessed 01/09/2013).